These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 89511)

  • 1. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
    Thom MH; White PJ; Williams RM; Sturdee DW; Paterson ME; Wade-Evans T; Studd JW
    Lancet; 1979 Sep; 2(8140):455-7. PubMed ID: 89511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
    Campbell S; McQueen J; Minardi J; Whitehead MI
    Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial disease after treatment with oestrogens and progestogens in the climacteric.
    Paterson ME; Wade-Evans T; Sturdee DW; Thom MH; Studd JW
    Br Med J; 1980 Mar; 280(6217):822-4. PubMed ID: 7370682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of endometrial cancer with progestogens.
    Gambrell RD
    Maturitas; 1986 Jul; 8(2):159-68. PubMed ID: 3747849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women.
    Sturdee DW; Wade-Evans T; Paterson ME; Thom M; Studd JW
    Br Med J; 1978 Jun; 1(6127):1575-7. PubMed ID: 656818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen-replacement therapy.
    Gambrell RD; Greenblatt RB
    Lancet; 1979 Nov; 2(8152):1138. PubMed ID: 91874
    [No Abstract]   [Full Text] [Related]  

  • 12. Scanning electron microscopy of the endometrial cell surface in postmenopausal women receiving oestrogen therapy.
    Thom MH; Davies KJ; Senkus RJ; Allen JM; Studd JW
    Br J Obstet Gynaecol; 1981 Sep; 88(9):904-13. PubMed ID: 7272263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen-replacement therapy.
    Stolley PD; Davies JL
    Lancet; 1979 Oct; 2(8146):800. PubMed ID: 90898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens, progestogens and endometrial cancer.
    Gambrell RD
    J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen therapy and endometrial cancer.
    Lancet; 1979 May; 1(8126):1121-2. PubMed ID: 86838
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in postmenopausal women treated with oestrogen.
    Ostergaard E
    Acta Obstet Gynecol Scand Suppl; 1974; 29():97-102. PubMed ID: 4526169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone therapy and the risk of cancer in the climacteric].
    Kuhl H; Taubert HD
    Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of endometrial abnormalities.
    Whitehead MI
    Acta Obstet Gynecol Scand Suppl; 1986; 134():81-91. PubMed ID: 3028029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of postmenopausal bleeding to prevent endometrial cancer.
    Gambrell RD; Castaneda TA; Ricci CA
    Maturitas; 1978 Sep; 1(2):99-106. PubMed ID: 755962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.